Raltegravir: in treatment-naive patients with HIV-1 infection.
about
Small Molecule Inhibitors of the LEDGF Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based DesignBicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.Allosteric inhibitor development targeting HIV-1 integrase.Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individualsBicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants.Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics.Cost-effectiveness of raltegravir in HIV/AIDS.Raltegravir: a review of its use in the management of HIV-1 infection in children and adolescents.Raltegravir Once-Daily Tablet: A Review in HIV-1 Infection.Limited sampling strategies for the estimation of raltegravir daily exposure in HIV-infected patients.
P2860
Q27670782-732FF170-6DFC-4FAF-863E-1AE8E657DBF7Q34080214-E0D7C908-5338-45E3-A66B-4C599D4AA2FFQ34435637-C83271BC-0B5A-4016-88EC-A28C1846CA40Q34900311-E8C1443B-D5A7-41C3-93AA-A816EBCB7FA3Q35046515-6699339C-3BB9-45D4-843A-C0BFC647A5D9Q36018556-FC808AC5-C733-466E-8337-8DC4F896888CQ37697384-C31719AF-81F0-46C7-BF42-88BA271E70F8Q37866298-CE39C270-8E45-4982-9E50-D5F48478B3E9Q37958046-6A2CE261-8761-4D10-B76A-887D8F3E9802Q38166286-DC9A86A7-1BAA-4372-85A2-E970DB4A7313Q50086057-ED5E2179-5379-49EA-A9F7-18540359E933Q51595257-86BEB3B4-FF55-427D-883D-7B3642FC47CB
P2860
Raltegravir: in treatment-naive patients with HIV-1 infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Raltegravir: in treatment-naive patients with HIV-1 infection.
@en
Raltegravir: in treatment-naive patients with HIV-1 infection.
@nl
type
label
Raltegravir: in treatment-naive patients with HIV-1 infection.
@en
Raltegravir: in treatment-naive patients with HIV-1 infection.
@nl
prefLabel
Raltegravir: in treatment-naive patients with HIV-1 infection.
@en
Raltegravir: in treatment-naive patients with HIV-1 infection.
@nl
P1433
P1476
Raltegravir: in treatment-naive patients with HIV-1 infection.
@en
P2093
Jamie D Croxtall
P304
P356
10.2165/11204590-000000000-00000
P577
2010-03-01T00:00:00Z
P6179
1010735244